Chemed (CHE) Accounts Payables (2009 - 2026)

Chemed's Accounts Payables history runs 18 years deep, the most recent figure standing at $65.7 million for Q1 2026.

• In Q1 2026, Accounts Payables rose 37.75% year-over-year to $65.7 million; the TTM figure through Mar 2026 stood at $65.7 million (up 37.75% YoY), while the FY2025 annual figure was $64.5 million, up 46.01% from the prior year.
• Accounts Payables was $65.7 million for Q1 2026 at Chemed, up from $64.5 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $77.2 million in Q3 2022 to a low of $40.3 million in Q1 2023.
• Historically, Accounts Payables has averaged $54.4 million across 5 years, with a median of $50.9 million in 2025.
• Biggest YoY gain for Accounts Payables was 52.88% in 2023; the steepest drop was 44.5% in 2023.
• A 5-year view of Accounts Payables shows it stood at $41.9 million in 2022, then soared by 52.88% to $64.0 million in 2023, then plunged by 31.06% to $44.1 million in 2024, then soared by 46.01% to $64.5 million in 2025, then rose by 1.92% to $65.7 million in 2026.
• The last three Accounts Payables figures came in at $65.7 million (Q1 2026), $64.5 million (Q4 2025), and $48.1 million (Q3 2025), per Business Quant data.